Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Net Asset Value(s)

1 Mar 2021 07:00

VanEck Vectors ETF's N.V. - Net Asset Value(s)

VanEck Vectors ETF's N.V. - Net Asset Value(s)

PR Newswire

London, March 1

Fund NameNAV DateTicker SymbolISINShares in IssueNet Asset ValueNAV per Share
VANECK AEX UCITS ETF 2021-02-26NL00092727492940000.000191642970.4565.1847
VANECK AMX UCITS ETF2021-02-26NL0009272756286000.00027738930.9196.9893
VANECK MULTI-ASSET BALANCED2021-02-26NL0009272772373000.00024030162.5064.4240
VANECK MULTI-ASSET GROWTH ALLO2021-02-26NL0009272780230000.00015789652.6268.6507
VANECK GLOBAL EQUAL WEIGHT2021-02-26NL00096902215691190.000266375950.5846.8050
VANECK GLOBAL REAL ESTATE2021-02-26NL00096902392935404.000102518095.0434.9247
VANECK IBOXX EUR CORPORATES2021-02-26NL00096902472528390.00047438564.1218.7624
VANECK IBOXX EUR SOV DIV 1-102021-02-26NL00096902542486537.00036040367.1514.4942
VANECK IBOXX EUR AAA-AA 1-52021-02-26NL00102738018351000.000174579228.7720.9052
VANECK EUR EQUAL WEIGHT UCITS 2021-02-26NL0010731816630000.00036764159.1458.3558
VANECK MORN N-AMERICA EQUAL2021-02-26NL0011376074215255.0008207929.4138.1312
VANECK MORN DM DIV LEADERS2021-02-26NL00116835941400000.00036981779.9126.4156
VANECK SUS WORLD EQUAL WEIGHT2021-02-26NL00104087041145000.000113149481.2698.8205
VANECK MULTI-ASSET CONSERVAT 2021-02-26NL0009272764258000.00015457478.0459.9127

Related Shares

Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.